Sprouts farmers market CEO Sinclair sells $827k in stock

Phoenix, AZ - Jack Sinclair, Chief Executive Officer of Sprouts Farmers Market Inc (NASDAQ:SFM), sold 8,090 shares of the company’s common stock on October 6th and 7th, 2025. The transaction comes as the stock trades near $104, down approximately 28% over the past six months, despite the company maintaining a strong financial health score of "GOOD" according to InvestingPro metrics. The sales, executed under a pre-arranged Rule 10b5-1 trading plan, resulted in proceeds of approximately $827,064.

On October 6, Sinclair sold 4,045 shares at a weighted average price of $102.9986, with individual sales prices ranging from $101.74 to $105.04. The following day, October 7, he sold another 4,045 shares at a weighted average price of $101.4674, with prices ranging from $100.105 to $102.930.

On the same dates, Sinclair exercised options to acquire 8,090 shares of Sprouts Farmers Market stock at a price of $16.47, for a total value of $133,242.

Following these transactions, Sinclair directly owns 174,740 shares of Sprouts Farmers Market, Inc., which includes 38,573 restricted stock units.

In other recent news, Sprouts Farmers Market reported stronger-than-expected second-quarter results, with same-store sales growth of 10.2%, surpassing analyst estimates of 9.0% and consensus expectations of 8.5%. This performance marked a 120 basis point sequential acceleration to 16.9% on a two-year stack basis. Additionally, Sprouts Farmers Market’s Board of Directors authorized a new $1 billion share repurchase program, replacing the previous authorization that had approximately $143 million remaining. The buyback program will allow the company to purchase shares through various means, including open market purchases and privately negotiated transactions.

In terms of stock ratings, Barclays upgraded Sprouts Farmers Market from Equalweight to Overweight, raising its price target to $185.00 from $173.00, citing confidence in the company’s growth outlook. Similarly, Wells Fargo upgraded the stock from Equal Weight to Overweight, increasing the price target to $180.00, viewing the recent stock pullback as a buying opportunity. On the other hand, UBS lowered its price target to $180.00 from $182.00 while maintaining a Neutral rating due to supply chain impacts. JPMorgan also assumed coverage with a Neutral rating, setting a price target of $159.00, down from the previous $165.00, yet acknowledged Sprouts’ favorable position in the health-conscious consumer market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.